Early in the pandemic, questions over vaccine safety increased as researchers started to track reports linking the COVID-19 mRNA vaccines to myocarditis in young adult males and adolescents, mostly after the second dose.
Since that time, however, the CDC’s surveillance efforts have demonstrated a significant decline in these cases.
"It seems that the risk was highest after that second dose of the initial series and we’re not seeing it at this point,” said Sean O’Leary, MD, professor of pediatrics at the University of Colorado School of Medicine and Children’s Hospital, Colorado, and chair of the American Academy of Pediatrics' Committee on Infectious Diseases.
CU Anschutz
Administrative Pavilion
13123 E. 16th Ave.
B065
Aurora, CO 80045